Breaking News Instant updates and real-time market news.

BCRX

BioCryst

$2.84

0.25 (9.65%)

04:55
12/02/19
12/02
04:55
12/02/19
04:55

BioCryst management to meet with JMP Securities

Meeting to be held in Boston on December 2 hosted by JMP Securities.

  • 02

    Dec

  • 03

    Dec

BCRX BioCryst
$2.84

0.25 (9.65%)

11/06/19
PIPR
11/06/19
NO CHANGE
Target $10
PIPR
Overweight
Piper says BCX7353 'viable,' BioCryst not getting credit for rest of pipeline
Piper Jaffray analyst Tyler Van Buren said following the presentation of new data showing that BCX7353 continues to show sustained efficacy through 48 weeks, he believes BCX7353 is an "approvable, viable" product that is also demonstrating durability. BioCryst also has several other products in the pipeline - such as BCX9930 and BCX9350 - are receiving no value from investors, added Van Buren, who keeps an Overweight rating and $10 price target on the shares.
11/15/19
BOFA
11/15/19
UPGRADE
BOFA
Buy
BioCryst upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill upgraded BioCryst to Buy from Neutral.
11/15/19
BOFA
11/15/19
UPGRADE
Target $4
BOFA
Buy
BioCryst upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Tazeen Ahmad upgraded BioCryst to Buy from Neutral but lowered his price target to $4, down from $5. The analyst says that he has conducted doctor checks after the release of the ApeX-2 study results in hereditary angioedema earlier this year to determine whether his peak sales estimates for the HAE market for '7353 seemed reasonable. Ahmad notes that while the doctors still gave preference to Takeda's Takhzyro as the best option given its superior efficacy and infrequent dosing, they also expressed interest in '7353 thanks to its oral dosing convenience. Ahmad adds that he has been on the sidelines on BioCryst because of its funding needs, but sees this week's $55M equity raise boosting its cash cushion.
11/15/19
11/15/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) upgraded to Buy from Neutral at Mizuho with analyst Vijay Rakesh saying much of Qualcomm's 4G handset risk is "in the rear view mirror," and the company is positioned well for 5G ramps in 2020 and 2021. 2. Applied Materials (AMAT) upgraded to Buy from Neutral at Nomura Instinet with analyst David Wong saying the copay last night reported sales for the October quarter that were above the original guidance midpoint, and guidance for the January 2020 quarter was meaningfully above consensus estimates. 3. GrubHub (GRUB) double upgraded to Overweight from Underweight at Barclays with analyst Deepak Mathivanan saying shares of GrubHub declined by 75% in 15 months given an "irrational" competitive landscape, "ill-timed" strategic investments, and poor execution. 4. BioCryst (BCRX) upgraded to Buy from Neutral at BofA/Merrill with analyst Tazeen Ahmad saying he has conducted doctor checks after the release of the ApeX-2 study results in hereditary angioedema earlier this year to determine whether his peak sales estimates for the HAE market for '7353 seemed reasonable. 5. Nvidia (NVDA) upgraded to Buy from Hold at Craig-Hallum with analyst Richard Shannon citing the company's "strong" Q3 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

INCY

Incyte

$92.79

-2.2 (-2.32%)

05:16
12/13/19
12/13
05:16
12/13/19
05:16
Recommendations
Incyte analyst commentary  »

Incyte risk/reward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

PCG

PG&E

$11.75

-0.38 (-3.13%)

05:14
12/13/19
12/13
05:14
12/13/19
05:14
Hot Stocks
PG&E files amended plan of reorganization »

PG&E Corporation and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

SRPT

Sarepta

$100.39

-1.15 (-1.13%)

05:12
12/13/19
12/13
05:12
12/13/19
05:12
Recommendations
Sarepta price target raised to $210 from $185 at Piper Jaffray »

Piper Jaffray analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOVE

Lovesac

$11.81

-2.68 (-18.50%)

05:07
12/13/19
12/13
05:07
12/13/19
05:07
Downgrade
Lovesac rating change  »

Lovesac downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 19

    Dec

TDOC

Teladoc

$77.06

-0.36 (-0.46%)

05:04
12/13/19
12/13
05:04
12/13/19
05:04
Initiation
Teladoc initiated  »

Teladoc initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTMI

TTM Technologies

$13.79

0.19 (1.40%)

05:01
12/13/19
12/13
05:01
12/13/19
05:01
Upgrade
TTM Technologies rating change  »

TTM Technologies upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FII

Federated Investors

$34.41

0.41 (1.21%)

05:01
12/13/19
12/13
05:01
12/13/19
05:01
Downgrade
Federated Investors rating change  »

Federated Investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMK

AssetMark Financial

$27.31

0.42 (1.56%)

05:00
12/13/19
12/13
05:00
12/13/19
05:00
Upgrade
AssetMark Financial rating change  »

AssetMark Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VCTR

Victory Capital

$21.68

0.235 (1.10%)

05:00
12/13/19
12/13
05:00
12/13/19
05:00
Downgrade
Victory Capital rating change  »

Victory Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EV

Eaton Vance

$47.08

0.395 (0.85%)

05:00
12/13/19
12/13
05:00
12/13/19
05:00
Upgrade
Eaton Vance rating change  »

Eaton Vance upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PZZA

Papa John's

$60.47

-0.37 (-0.61%)

04:59
12/13/19
12/13
04:59
12/13/19
04:59
Initiation
Papa John's initiated  »

Papa John's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

NGLOY

Anglo American

$0.00

(0.00%)

04:57
12/13/19
12/13
04:57
12/13/19
04:57
Downgrade
Anglo American rating change  »

Anglo American assumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
12/13/19
12/13
04:55
12/13/19
04:55
General news
Retail Sales less autos to be reported at 08:30 »

November Retail Sales…

04:55
12/13/19
12/13
04:55
12/13/19
04:55
General news
Breaking General news story  »

New York Federal Reserve…

04:55
12/13/19
12/13
04:55
12/13/19
04:55
General news
Breaking General news story  »

New York Federal Reserve…

ACB

Aurora Cannabis

$2.61

0.15 (6.10%)

, CRON

Cronos Group

$7.31

0.49 (7.18%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
MJBizDaily to hold a conference »

Marijuana Business…

ACB

Aurora Cannabis

$2.61

0.15 (6.10%)

CRON

Cronos Group

$7.31

0.49 (7.18%)

NFX

Newfield Exploration

$0.00

(0.00%)

CGC

Canopy Growth

$21.14

0.84 (4.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASML

ASML

$287.22

3.3 (1.16%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
ASML management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

UBX

Unity Biotechnology

$8.30

0.61 (7.93%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Recommendations
Unity Biotechnology analyst commentary  »

Unity Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

COUP

Coupa Software

$136.91

-7.2 (-5.00%)

, CRWD

Crowdstrike

$47.25

-0.49 (-1.03%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
FBN to hold a bus tour »

17th Semi-Annual Silicon…

COUP

Coupa Software

$136.91

-7.2 (-5.00%)

CRWD

Crowdstrike

$47.25

-0.49 (-1.03%)

FEYE

FireEye

$16.33

0.095 (0.59%)

FSCT

ForeScout

$34.24

0.73 (2.18%)

FTNT

Fortinet

$104.45

0.29 (0.28%)

NOW

ServiceNow

$265.76

-1.665 (-0.62%)

NTAP

NetApp

$62.73

2.12 (3.50%)

PFPT

Proofpoint

$112.97

-0.03 (-0.03%)

PSTG

Pure Storage

$16.50

0.16 (0.98%)

QLYS

Qualys

$84.80

0.46 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 17

    Dec

  • 06

    Jan

  • 08

    Jan

  • 13

    Jan

  • 10

    Mar

  • 11

    Mar

  • 09

    Dec

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
BTIG biotech analysts to hold an analyst/industry conference call »

Biotech Analysts, along…

EA

Electronic Arts

$105.08

1.9 (1.84%)

, ATVI

Activision Blizzard

$58.60

2.12 (3.75%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
Wedbush digital media analyst to hold an analyst/industry conference call »

Digital Media Analyst…

EA

Electronic Arts

$105.08

1.9 (1.84%)

ATVI

Activision Blizzard

$58.60

2.12 (3.75%)

GME

GameStop

$5.58

0.05 (0.90%)

NTDOY

Nintendo

$0.00

(0.00%)

TTWO

Take-Two

$125.33

2.95 (2.41%)

UBSFY

Ubisoft

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

OGI

Organigram

$2.57

(0.00%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
Organigram management to meet with Cantor Fitzgerald »

Analyst Pablo Zuanic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

ABB

ABB

$23.62

0.685 (2.99%)

, MMM

3M

$168.54

-0.19 (-0.11%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
Wolfe Research to hold a field trip »

European Multi-Industry…

ABB

ABB

$23.62

0.685 (2.99%)

MMM

3M

$168.54

-0.19 (-0.11%)

SCHN

Schnitzer Steel

$22.39

0.22 (0.99%)

UTX

United Technologies

$149.49

2.2 (1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

TTWO

Take-Two

$125.33

2.95 (2.41%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
Take-Two management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

HY

Hyster-Yale Materials

$64.70

1.14 (1.79%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
Hyster-Yale Materials management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 26

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.